Proteomics-based identification of α1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas

Bechr Hamrita, Karim Chahed, Mounir Trimeche, Christelle Lemaitre Guillier, Philippe Hammann, Anouar Chaïeb, Sadok Korbi, Lotfi Chouchane

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Background: The identification of pathological markers of breast cancer for either diagnosis, treatment response or for survival is of critical importance. Methods: Serum protein profiling using 2-DE separations coupled to matrix-assisted laser desorption ionization mass spectrometry has been used to explore protein alterations in patients with infiltrating ductal breast carcinomas (IDCA). Sera from 39 breast cancer patients and 40 healthy controls were selected for screening study using 2-DE combined with MS. The protein expression patterns obtained after the depletion of high abundance proteins was determined by coomassie blue G-250 stain after 2-DE electrophoresis. Results: Six proteins that expressed differentially in the IDCA group were found. The expression levels of four isoforms corresponding to haptoglobin precursor and two isoforms of α1-antitrypsin precursor (α1-AT) were upregulated in sera from breast cancer patients. There was an increased expression of both proteins in the sera of patients with various tumor stages (I, II, III) in comparison to healthy women. Applying immunohistochemistry, we further validated α1-AT immunoreactivity in 51 formalin-fixed paraffin-embedded sections of breast tumors. Enhanced expression of α1-AT like activity has been found in IDCA breast tumors, as well as, in different histological types of breast cancer. No significant association has been found with lymph node occurrence, while in high tumor categories a tendency to an increased expression of α1-AT has been found, thereby suggesting a possible role of this protein in tumor growth. Conclusions: These proteins may constitute new and useful markers of breast cancer that offer a clue to a better understanding of inflammatory pathways and carcinogenesis events linked to breast cancer progression.

Original languageEnglish
Pages (from-to)111-118
Number of pages8
JournalClinica Chimica Acta
Volume404
Issue number2
DOIs
Publication statusPublished - 27 Jun 2009
Externally publishedYes

Fingerprint

Carcinoma, Ductal, Breast
Haptoglobins
Proteomics
Biomarkers
Breast Neoplasms
Tumors
Proteins
Protein Isoforms
Blood Proteins
Neoplasms
Electrophoresis
Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry
Paraffin
Formaldehyde
Ionization
Mass spectrometry
Serum
Desorption
Screening
Coloring Agents

Keywords

  • Infiltrating ductal breast carcinomas
  • Serological proteome analysis
  • Tumor marker

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Proteomics-based identification of α1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas. / Hamrita, Bechr; Chahed, Karim; Trimeche, Mounir; Guillier, Christelle Lemaitre; Hammann, Philippe; Chaïeb, Anouar; Korbi, Sadok; Chouchane, Lotfi.

In: Clinica Chimica Acta, Vol. 404, No. 2, 27.06.2009, p. 111-118.

Research output: Contribution to journalArticle

Hamrita, Bechr ; Chahed, Karim ; Trimeche, Mounir ; Guillier, Christelle Lemaitre ; Hammann, Philippe ; Chaïeb, Anouar ; Korbi, Sadok ; Chouchane, Lotfi. / Proteomics-based identification of α1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas. In: Clinica Chimica Acta. 2009 ; Vol. 404, No. 2. pp. 111-118.
@article{55a1462f7b2347a9b36d54a801691b69,
title = "Proteomics-based identification of α1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas",
abstract = "Background: The identification of pathological markers of breast cancer for either diagnosis, treatment response or for survival is of critical importance. Methods: Serum protein profiling using 2-DE separations coupled to matrix-assisted laser desorption ionization mass spectrometry has been used to explore protein alterations in patients with infiltrating ductal breast carcinomas (IDCA). Sera from 39 breast cancer patients and 40 healthy controls were selected for screening study using 2-DE combined with MS. The protein expression patterns obtained after the depletion of high abundance proteins was determined by coomassie blue G-250 stain after 2-DE electrophoresis. Results: Six proteins that expressed differentially in the IDCA group were found. The expression levels of four isoforms corresponding to haptoglobin precursor and two isoforms of α1-antitrypsin precursor (α1-AT) were upregulated in sera from breast cancer patients. There was an increased expression of both proteins in the sera of patients with various tumor stages (I, II, III) in comparison to healthy women. Applying immunohistochemistry, we further validated α1-AT immunoreactivity in 51 formalin-fixed paraffin-embedded sections of breast tumors. Enhanced expression of α1-AT like activity has been found in IDCA breast tumors, as well as, in different histological types of breast cancer. No significant association has been found with lymph node occurrence, while in high tumor categories a tendency to an increased expression of α1-AT has been found, thereby suggesting a possible role of this protein in tumor growth. Conclusions: These proteins may constitute new and useful markers of breast cancer that offer a clue to a better understanding of inflammatory pathways and carcinogenesis events linked to breast cancer progression.",
keywords = "Infiltrating ductal breast carcinomas, Serological proteome analysis, Tumor marker",
author = "Bechr Hamrita and Karim Chahed and Mounir Trimeche and Guillier, {Christelle Lemaitre} and Philippe Hammann and Anouar Cha{\"i}eb and Sadok Korbi and Lotfi Chouchane",
year = "2009",
month = "6",
day = "27",
doi = "10.1016/j.cca.2009.03.033",
language = "English",
volume = "404",
pages = "111--118",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Proteomics-based identification of α1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas

AU - Hamrita, Bechr

AU - Chahed, Karim

AU - Trimeche, Mounir

AU - Guillier, Christelle Lemaitre

AU - Hammann, Philippe

AU - Chaïeb, Anouar

AU - Korbi, Sadok

AU - Chouchane, Lotfi

PY - 2009/6/27

Y1 - 2009/6/27

N2 - Background: The identification of pathological markers of breast cancer for either diagnosis, treatment response or for survival is of critical importance. Methods: Serum protein profiling using 2-DE separations coupled to matrix-assisted laser desorption ionization mass spectrometry has been used to explore protein alterations in patients with infiltrating ductal breast carcinomas (IDCA). Sera from 39 breast cancer patients and 40 healthy controls were selected for screening study using 2-DE combined with MS. The protein expression patterns obtained after the depletion of high abundance proteins was determined by coomassie blue G-250 stain after 2-DE electrophoresis. Results: Six proteins that expressed differentially in the IDCA group were found. The expression levels of four isoforms corresponding to haptoglobin precursor and two isoforms of α1-antitrypsin precursor (α1-AT) were upregulated in sera from breast cancer patients. There was an increased expression of both proteins in the sera of patients with various tumor stages (I, II, III) in comparison to healthy women. Applying immunohistochemistry, we further validated α1-AT immunoreactivity in 51 formalin-fixed paraffin-embedded sections of breast tumors. Enhanced expression of α1-AT like activity has been found in IDCA breast tumors, as well as, in different histological types of breast cancer. No significant association has been found with lymph node occurrence, while in high tumor categories a tendency to an increased expression of α1-AT has been found, thereby suggesting a possible role of this protein in tumor growth. Conclusions: These proteins may constitute new and useful markers of breast cancer that offer a clue to a better understanding of inflammatory pathways and carcinogenesis events linked to breast cancer progression.

AB - Background: The identification of pathological markers of breast cancer for either diagnosis, treatment response or for survival is of critical importance. Methods: Serum protein profiling using 2-DE separations coupled to matrix-assisted laser desorption ionization mass spectrometry has been used to explore protein alterations in patients with infiltrating ductal breast carcinomas (IDCA). Sera from 39 breast cancer patients and 40 healthy controls were selected for screening study using 2-DE combined with MS. The protein expression patterns obtained after the depletion of high abundance proteins was determined by coomassie blue G-250 stain after 2-DE electrophoresis. Results: Six proteins that expressed differentially in the IDCA group were found. The expression levels of four isoforms corresponding to haptoglobin precursor and two isoforms of α1-antitrypsin precursor (α1-AT) were upregulated in sera from breast cancer patients. There was an increased expression of both proteins in the sera of patients with various tumor stages (I, II, III) in comparison to healthy women. Applying immunohistochemistry, we further validated α1-AT immunoreactivity in 51 formalin-fixed paraffin-embedded sections of breast tumors. Enhanced expression of α1-AT like activity has been found in IDCA breast tumors, as well as, in different histological types of breast cancer. No significant association has been found with lymph node occurrence, while in high tumor categories a tendency to an increased expression of α1-AT has been found, thereby suggesting a possible role of this protein in tumor growth. Conclusions: These proteins may constitute new and useful markers of breast cancer that offer a clue to a better understanding of inflammatory pathways and carcinogenesis events linked to breast cancer progression.

KW - Infiltrating ductal breast carcinomas

KW - Serological proteome analysis

KW - Tumor marker

UR - http://www.scopus.com/inward/record.url?scp=67349192924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349192924&partnerID=8YFLogxK

U2 - 10.1016/j.cca.2009.03.033

DO - 10.1016/j.cca.2009.03.033

M3 - Article

VL - 404

SP - 111

EP - 118

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

IS - 2

ER -